Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BKF Capital Group, Inc. is a publicly traded investment management firm that historically operated through its subsidiary, Baker Capital. While the company has a long history in the financial services sector, it is not primarily a life sciences, biotech, or healthcare company. Its business model focuses on asset management and investment advisory services across various industries. In recent years, the company has undergone significant corporate restructuring and changes in its investment focus. It is currently listed on the OTC markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BKF.